
Elizabeth Marion Jaffee MD
Gastrointestinal Cancer
Professor of Oncology and Professor of Pathology, Johns Hopkins University School of Medicine; The Dana and Albert "Cubby" Broccoli Professor of Oncology; Co-Director, Skip Viragh Center for Pancreas Cancer; Co-Director, Gastrointestinal Cancers Program; Co-Director of the Cancer Immunology Program and the Immunology and Hematopoiesis Division
Join to view full profile
600 N Wolfe StBaltimore, MD 21287
Phone+1 410-955-8964
Dr. Jaffee is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
UPMC Medical EducationInternship, Internal Medicine, 1985 - 1986
New York Medical CollegeClass of 1985
Certifications & Licensure
MD State Medical License 1989 - 2026
PA State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.S Daniel Haldar, Meredith Wetzel, Jiayun Lu, Jae W Lee, Hassan Sinan
Clinical Cancer Research. 2026-08-14 - Modernizing Drug Development for Exceptional Therapies in High‑Unmet Need Diseases: A Call for Pragmatism and Patient Centricity.Elizabeth M Jaffee, Timothy A Yap
Journal of Clinical Oncology. 2026-08-06 - Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial.Eric S Christenson, Jeremiah A Wala, Rose Parkinson, Natalie B Collins, Christopher Jakubowski
Nature Communications. 2026-07-23
Journal Articles
- Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology ClinicMark Yarchoan, Elizabeth Jaffee, Annals of Oncology
Press Mentions
Researchers Hope the New Drug Is Just the Beginning, Opening a New Chapter in Treatment for a Range of Cancer TypesAugust 27th, 2026
How an ‘Impossible’ Idea Led to a Pancreatic Cancer BreakthroughMay 12th, 2026
HHS Has a Potential Solution for Cancers That Keep Coming Back: VaccinesMarch 17th, 2026
Grant Support
- Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical TrialJOHNS HOPKINS UNIVERSITY2015–2031
- Targeting HMGA1 Tumor-Stromal Networks in Pancreatic CarcinogenesisJOHNS HOPKINS UNIVERSITY2024–2029
- Transforming Human Pancreatic Cancer Into An Immunologic DiseaseJOHNS HOPKINS UNIVERSITY2021–2026
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/elizabeth-jaffee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









